Medicine & Life Sciences
Asthma
100%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
41%
Mevalonic Acid
38%
Simvastatin
36%
Lung
32%
Chronic Obstructive Pulmonary Disease
30%
Unfolded Protein Response
24%
Autophagy
19%
Therapeutics
18%
Idiopathic Pulmonary Fibrosis
18%
Ovalbumin
16%
Inflammation
15%
Epoxide Hydrolases
13%
Arginase
13%
farnesyl pyrophosphate
11%
Cholesterol
11%
fluticasone furoate-vilanterol trifenatate
11%
Pharmaceutical Preparations
10%
Prenylation
9%
Farnesyltranstransferase
9%
Arginine
9%
Tracheobronchopathia osteoplastica
8%
Clinical Trials
8%
Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome
8%
Goblet Cells
8%
Interstitial Lung Diseases
8%
Nitric Oxide
8%
Heart Neoplasms
8%
Heart Diseases
8%
rho GTP-Binding Proteins
8%
Bronchoalveolar Lavage Fluid
7%
Thyroid Crisis
7%
Lung Diseases
7%
Terpenes
7%
pitavastatin
7%
Myotoxicity
7%
Pneumonia
7%
Monomeric GTP-Binding Proteins
7%
Airway Remodeling
7%
angiotensin converting enzyme 2
7%
piperidine
7%
ras Proteins
7%
Interleukin-13
7%
Cytokines
7%
Apoptosis
6%
SARS Virus
6%
Guanosine Triphosphate
6%
Pharmacology
6%
Pravastatin
6%
Endoplasmic Reticulum Stress
6%
Chemical Compounds
Hydrolase Inhibitor
15%
Pharmacological Metabolism
11%
Smoke
11%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
10%
Mevalonate
9%
Protein
9%
Nitric Oxide
9%
Epoxide
8%
Lipid
8%
Simvastatin
8%
High-Density Lipoprotein Cholesterol
7%
Prenylation
7%
Immunosorbent
6%
Cholesterol
6%
Drug
6%
Antiviral Agent
6%
Dexamethasone
6%
Angiotensin
6%
L-Arginine
6%
High-Density Lipoprotein
6%
Nicotine
6%
Biological Marker
5%
Dust
5%
Volatile Organic Compound
5%
Metabolic
5%
Vitamin
5%